A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment

作者：Elizur S E^*; Son W Y; Clarke H; Morris D; Gidoni Y; Demirtas E; Tan S L

来源：Reproductive BioMedicine Online, 2011, 22(3): 257-262.

DOI：10.1016/j.rbmo.2010.11.012

• corpus luteum
• dominant follicle
• fertility preservation
• folliculogenesis
• IVM

The aim of this study was to identify the size in which the dominant follicle acquires the ability to produce a functional corpus luteum. This observational study includes 15 women with ovulatory cycles who underwent human chorionic gonadotrophin (HCG)-primed in-vitro maturation (IVM) treatments without embryo transfer. All patients received subcutaneous injection of HCG 10,000 IU 38 h prior to oocyte retrieval. Five to seven days following retrieval, serum concentrations of progesterone and oestradiol were measured along with ultrasound scan measuring the antral follicle count. Using receiver operating characteristic curves and the Youden index (J), this study clearly shows that the diameter of the dominant follicle at the time of the LH surge is a good predictor for its ability to form a progesterone-producing corpus luteum (area under the curve 0.94). These findings revealed that the dominant follicle develops the competence to form a corpus luteum, signified by the production of more than 10 nmol/l serum progesterone at 5-7 days from oocyte retrieval, as soon as it acquires a diameter of 10.5-12.0 mm. In addition, a new cohort of viable antral follicles can be identified as early as 5-7 days following IVM oocyte retrieval.

• 出版日期2011-3
• 单位McGill